세계의 소비자 직접 유전자 검사 시장 - 산업 규모, 점유율, 동향, 기회 및 예측(검사 유형별, 기술별, 검체별, 유통 채널별, 지역별, 경쟁별, 2020-2030년)

Direct-To-Consumer Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By Sample, By Distribution Channel, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,601,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,068,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,736,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 소비자 직접 유전자 검사 시장은 2024년에 19억 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 8.64%를 나타내 31억 2,000만 달러에 이를 것으로 예측됩니다.

소비자 직접 유전자 검사(DTC)는 의료 제공업체의 소개를 필요로 하지 않으며 개인이 직접 유전자 분석을 구매하고 조상, 건강 위험, 개인화된 웰빙에 대한 지식을 얻는 것을 의미합니다. 시장 확대는 유전적 소인에 대한 일반 인식 증가와 개인화된 건강에 대한 지식에 대한 소비자 관심 증가가 근본적인 원동력이 되고 있습니다. DNA 시퀀싱 기술의 진보에 의해 보다 저렴하고 접근하기 쉬운 검사가 가능하게 된 것도, 이 시장을 크게 추진하고 있습니다.

시장 개요
예측 기간	2026-2030
시장 규모(2024년)	19억 달러
시장 규모(2030년)	31억 2,000만 달러
CAGR(2025-2030년)	8.64%
가장 빠르게 성장하는 부문	조상 및 친족 관계 검사
가장 큰 시장	북미

주요 시장 성장 촉진요인

소비자의 건강 의식의 높아짐과 건강 관리에 대한 적극적인 대처가 소비자 직접 유전자 검사 시장의 기반이 되는 추진력이 되고 있습니다. 개인은 다양한 질병에 대한 유전적 소인을 이해하고 정보에 근거한 생활습관의 결정과 예방책을 이끌기 위해 개인화된 건강정보를 입수할 의욕을 점점 더 높여가고 있습니다.

주요 시장 과제

세계의 소비자 직접 유전자 검사 시장은 데이터 프라이버시에 대한 지속적인 우려와 기밀성이 높은 유전자 정보 공유와 관련된 윤리적 과제의 형태로 큰 장벽에 직면하고 있습니다. 이 과제는 소비자의 신뢰와 DTC 검사 플랫폼에 대한 참여 의욕에 직접 영향을 미치며 시장 전체의 확대를 제한합니다.

주요 시장 동향

디지털 헬스 및 인공지능(AI) 분석과의 통합은 유전자 데이터의 해석과 유용성을 높여 세계의 소비자 직접 유전자 검사 시장을 근본적으로 변화시키고 있습니다. 이 추세는 단순한 데이터 제공을 넘어 복잡한 유전체 정보를 개인에게 최적화된 실습 가능한 건강 정보로 변환하는 고급 분석을 가능하게 합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율·예측
  • 검사 유형별(조상 및 친족 관계 검사, 예측 검사, 영양유전체 검사, 보인자 검사, 피부 관리 검사, 기타)
  • 기술별(단일 염기 다형성(SNP) 칩, 표적 분석, 전장 유전체 염기서열 분석(WGS), 기타)
  • 검체별(타액, 소변, 혈액, 기타)
  • 유통 채널별(온라인, 오프라인)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카

제10장 남미의 소비자 직접 유전자 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병 및 인수
• 제품 출시
• 최근 동향

제13장 세계의 소비자 직접 유전자 검사 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• 23andMe, Inc
• Ancestry.com, LLC
• Color Health, Inc
• Helix, Inc.
• Counsyl, Inc.
• MyHeritage Ltd.
• Living DNA Ltd.
• Mapmygenome India Limited
• Full Genomes Corporation, Inc
• Direct Laboratory Services, LLC

제16장 전략적 제안

제17장 기업 소개와 면책사항

KTH

영문 목차

영문목차

The Global Direct-To-Consumer (DTC) Genetic Testing Market , valued at USD 1.90 Billion in 2024, is projected to experience a CAGR of 8.64% to reach USD 3.12 Billion by 2030. Direct-to-Consumer (DTC) genetic testing involves individuals directly purchasing genetic analyses to obtain insights into ancestry, health risks, and personalized wellness without requiring a healthcare provider's referral. The market's expansion is fundamentally driven by increasing public awareness regarding genetic predispositions and a growing consumer interest in personalized health insights. Advancements in DNA sequencing technologies, leading to more affordable and accessible testing, also significantly propel this market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.90 Billion
Market Size 2030	USD 3.12 Billion
CAGR 2025-2030	8.64%
Fastest Growing Segment	Ancestry & Relationship Testing
Largest Market	North America

Key Market Drivers

Growing consumer health awareness and a proactive approach to health management serve as a foundational driver for the Direct-To-Consumer genetic testing market. Individuals are increasingly motivated to acquire personalized health insights, seeking to understand genetic predispositions for various conditions and to guide informed lifestyle decisions and preventive measures. This heightened consumer engagement is well-documented, with reports showing that, according to the Journal of Community Genetics, in 2023, 77.0% of DTC DNA online news articles asserted that DTC DNA testing enhances awareness regarding genetic diseases, illustrating the expanding societal recognition of genetic information for personal health empowerment. Complementing this, continuous advancements in genetic sequencing technologies have fundamentally reshaped the market by drastically improving the accessibility and affordability of these sophisticated tests. Breakthroughs in next-generation sequencing have not only yielded significant improvements in the speed and accuracy of genetic analysis but have also driven down the economic barrier to entry.

Key Market Challenges

The global Direct-to-Consumer genetic testing market encounters a substantial impediment in the form of persistent concerns surrounding data privacy and the ethical implications associated with the sharing of sensitive genetic information. This challenge directly impacts consumer confidence and willingness to engage with DTC testing platforms, thereby restricting the market's overall expansion. Potential users often harbor reservations about how their unique genetic blueprints are stored, accessed, and potentially utilized by third parties, leading to a cautious approach towards adoption.

Key Market Trends

Integration with digital health and artificial intelligence (AI) analytics is fundamentally reshaping the Global Direct-To-Consumer (DTC) Genetic Testing Market by enhancing the interpretation and utility of genetic data. This trend moves beyond simple data provision, enabling sophisticated analysis that translates complex genomic information into personalized and actionable health insights. AI-powered platforms can identify intricate patterns within vast genetic datasets, leading to more refined risk assessments and tailored wellness recommendations. According to the American Clinical Laboratory Association's (ACLA) 2025 advocacy agenda, there is a clear focus on promoting policies that support innovation within clinical laboratories, including the adoption of AI to enhance testing services.

Key Market Players

• 23andMe, Inc
• Ancestry.com, LLC
• Color Health, Inc
• Helix, Inc.
• Counsyl, Inc.
• MyHeritage Ltd.
• Living DNA Ltd.
• Mapmygenome India Limited
• Full Genomes Corporation, Inc
• Direct Laboratory Services, LLC

Report Scope:

In this report, the Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Direct-To-Consumer (DTC) Genetic Testing Market , By Test Type:

• Ancestry & Relationship Testing
• Predictive Testing
• Nutrigenomic Testing
• Carrier Testing
• Skincare Testing
• Others

Direct-To-Consumer (DTC) Genetic Testing Market , By Technology:

• Single Nucleotide Polymorphism (SP) chips
• Targeted Analysis
• Whole Genome Sequencing (WGS)
• Others

Direct-To-Consumer (DTC) Genetic Testing Market , By Sample:

• Saliva
• Urine
• Blood
• Others

Direct-To-Consumer (DTC) Genetic Testing Market , By Distribution Channel:

• Online
• Offline

Direct-To-Consumer (DTC) Genetic Testing Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Direct-To-Consumer (DTC) Genetic Testing Market .

Available Customizations:

Global Direct-To-Consumer (DTC) Genetic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Ancestry & Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others)
  • 5.2.2. By Technology (Single Nucleotide Polymorphism (SP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others)
  • 5.2.3. By Sample (Saliva, Urine, Blood, Others)
  • 5.2.4. By Distribution Channel (Online, Offline)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Technology
  • 6.2.3. By Sample
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Sample
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Sample
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Sample
      • 6.3.3.2.4. By Distribution Channel

7. Europe Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Technology
  • 7.2.3. By Sample
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Sample
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Sample
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Sample
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Sample
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Sample
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Technology
  • 8.2.3. By Sample
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Sample
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Sample
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Sample
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Sample
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Sample
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Technology
  • 9.2.3. By Sample
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Sample
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Sample
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Sample
      • 9.3.3.2.4. By Distribution Channel

10. South America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Technology
  • 10.2.3. By Sample
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Sample
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Sample
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Sample
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Direct-To-Consumer (DTC) Genetic Testing Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 23andMe, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ancestry.com, LLC
• 15.3. Color Health, Inc
• 15.4. Helix, Inc.
• 15.5. Counsyl, Inc.
• 15.6. MyHeritage Ltd.
• 15.7. Living DNA Ltd.
• 15.8. Mapmygenome India Limited
• 15.9. Full Genomes Corporation, Inc
• 15.10. Direct Laboratory Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료